查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1618200

血流動力學監測設備市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

Hemodynamic Monitoring Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球血流動力學監測設備市場價值14 億美元，預計2024 年至2032 年複合年成長率為6.7%。血流和壓力。它們提供關鍵生理參數的即時資料，例如心輸出量、血壓、氧合水平和血管阻力，使醫療保健提供者能夠有效評估心臟功能和體液平衡。包括心臟病和高血壓在內的心血管疾病的盛行率不斷上升，是市場成長的重要動力。血流動力學監測設備對於管理慢性和急性心血管疾病、指導治療和改善患者預後是不可或缺的。

從產品來看，血流動力學監測設備市場分為一次性用品和監視器。 2023 年一次性用品部分的價值為 4.379 億美元。在重症監護環境中，患者的免疫系統通常受到損害，導管、壓力感測器和電極等無菌一次性物品對於防止病原體傳播至關重要。根據系統類型，血流動力學監測設備市場分為非侵入性、侵入性和微創細分市場。

非侵入性細分市場在 2023 年佔據主導地位，營收為 7.192 億美元，預計在預測期內複合年成長率為 6.8%。醫療保健提供者和患者越來越傾向於微創或非侵入性醫療保健選擇。與傳統的侵入性監測系統相比，非侵入性血流動力學監測設備越來越受歡迎，因為它們能夠降低併發症風險、最大限度地減少患者不適並縮短恢復時間。此外，感測器技術、無線通訊和資料處理的技術進步提高了非侵入性血流動力學監測設備的準確性和可靠性。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 14億美元
預測值 25億美元
複合年成長率 6.7%

預計到2032 年，北美血流動力學監測設備市場將達到8.881 億美元。美元，凸顯了對先進監控系統的迫切需求。鑑於這些疾病的高發生率，準確可靠的血流動力學監測對於有效管理這些疾病至關重要。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 全球慢性病發生率上升
      • 血流動力學監測設備的技術進步
      • 擴大採用遠端血流動力學監測設備
      • 人們越來越喜歡遠距醫療服務
    • 產業陷阱與挑戰
      • 病患監護設備成本高
      • 嚴格的監管框架
  • 成長潛力分析
  • 監管環境
    • 美國
    • 歐洲
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

  • 主要趨勢
  • 免洗用品
  • 顯示器

第 6 章：市場估計與預測：按系統類型，2021 - 2032 年

  • 主要趨勢
  • 非侵入性
  • 侵入性
  • 微創

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 家庭護理設置
  • 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 9 章：公司簡介

  • Abbott Laboratories
  • Baxter International
  • Canon Medical Systems Corporation
  • Deltex Medical Group
  • Edwards Lifesciences Corporation
  • GE HealthCare Technologies
  • Getinge
  • ICU Medical
  • Koninklijke Philips NV
  • Masimo Corporation
  • Nihon Kohden Corporation
  • OSYPKA MEDICAL
  • Siemens Healthineers
簡介目錄
Product Code: 7995

The Global Hemodynamic Monitoring Devices Market was worth USD 1.4 billion in 2023, with an estimated CAGR of 6.7% from 2024 to 2032. These devices are crucial for assessing and tracking cardiovascular performance, specifically monitoring blood flow and pressure within the circulatory system. They provide real-time data on critical physiological parameters, such as cardiac output, blood pressure, oxygenation levels, and vascular resistance, enabling healthcare providers to evaluate heart function and fluid balance effectively. The increasing prevalence of cardiovascular conditions, including heart disease and hypertension, is a significant driver of market growth. Hemodynamic monitoring devices are indispensable for managing chronic and acute cardiovascular conditions, guiding treatment, and improving patient outcomes.

In terms of products, the hemodynamic monitoring device market is divided into disposables and monitors. The disposables segment was valued at USD 437.9 million in 2023. Single-use disposables are essential for minimizing the risk of cross-contamination and hospital-acquired infections (HAIs). In critical care settings, where patients often have compromised immune systems, sterile single-use items like catheters, pressure transducers, and electrodes are vital for preventing pathogen transmission. Based on system type, the hemodynamic monitoring devices market is divided into non-invasive, invasive, and minimally invasive segments.

The non-invasive segment dominated in 2023 with a revenue of USD 719.2 million, and it is expected to grow at a CAGR of 6.8% over the forecast period. There is a growing preference for minimally invasive or non-invasive healthcare options among healthcare providers and patients. Non-invasive hemodynamic monitoring devices are increasingly popular because of their ability to reduce complication risks, minimize patient discomfort, and shorten recovery times compared with traditional invasive monitoring systems. Additionally, technological advancements in sensor technology, wireless communication, and data processing have enhanced the accuracy and reliability of non-invasive hemodynamic monitoring devices.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1.4 Billion
Forecast Value$2.5 Billion
CAGR6.7%

North America hemodynamic monitoring devices market is forecast to reach USD 888.1 million by 2032. U.S. market held a revenue of USD 470.5 million in 2023, driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders across the region, highlighting the critical need for advanced monitoring systems. Accurate and reliable hemodynamic monitoring is essential for effectively managing these conditions, given the high incidence rates.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of chronic diseases across the globe
      • 3.2.1.2 Technological advancements in hemodynamic monitoring devices
      • 3.2.1.3 Growing adoption of remote hemodynamic monitoring devices
      • 3.2.1.4 Growing preference for telehealth services
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of patient monitoring devices
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Disposables
  • 5.3 Monitors

Chapter 6 Market Estimates and Forecast, By System Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Non-invasive
  • 6.3 Invasive
  • 6.4 Minimally invasive

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Homecare settings
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Baxter International
  • 9.3 Canon Medical Systems Corporation
  • 9.4 Deltex Medical Group
  • 9.5 Edwards Lifesciences Corporation
  • 9.6 GE HealthCare Technologies
  • 9.7 Getinge
  • 9.8 ICU Medical
  • 9.9 Koninklijke Philips N.V.
  • 9.10 Masimo Corporation
  • 9.11 Nihon Kohden Corporation
  • 9.12 OSYPKA MEDICAL
  • 9.13 Siemens Healthineers